Chemokines in islet allograft rejection

Diabetes/Metabolism Research and Reviews

Volumn 19, Issue 3, 2003, Pages 186-190

  Abdi, Reza ^a   Means, Terry K ^b   Luster, Andrew D ^b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Chemokine receptor 5; Islet allograft rejection; Organ specificity of chemokines; Th2 response

Indexed keywords

CHEMOKINE; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR3; LIGAND;

ACUTE GRAFT REJECTION; CELL DIFFERENTIATION; CELL MATURATION; CELLULAR DISTRIBUTION; DRUG TARGETING; GRAFT REJECTION; GRAFT SURVIVAL; HEART GRAFT; HEART MUSCLE BIOPSY; HUMAN; IMMUNE RESPONSE; KIDNEY ALLOGRAFT; KIDNEY BIOPSY; LEUKOCYTE; NONHUMAN; PANCREAS ISLET TRANSPLANTATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; REVIEW; TH1 CELL;

ACUTE DISEASE; ANIMALS; CHEMOKINES; GENE EXPRESSION REGULATION; GRAFT REJECTION; HUMANS; ISLETS OF LANGERHANS TRANSPLANTATION; TH1 CELLS; TH2 CELLS;

EID: 0038280157     PISSN: 15207552     EISSN: None     Source Type: Journal    
DOI: 10.1002/dmrr.362     Document Type: Review

References (24)

1. Luster AD. Chemokines-chemotactic cytokines that mediate inflammation. N Engl J Med 1998; 338(7): 436-445.
2. Baggiolini M. Chemokines and leukocyte traffic. Nature 1998; 392(6676): 565-568.
3. Luster AD. The role of chemokines in linking innate and adaptive immunity. Curr Opin Immunol 2002; 14(1): 129-135.
4. Murphy PM, Baggiolini M, Charo IF, et al. International union of pharmacology. XXII. Nomenclature for chemokine receptors. Pharmacol Rev 2000; 52(1): 145-176.
5. Muller A, Homey B, Soto H, et al. Involvement of chemokine receptors in breast cancer metastasis. Nature 2001; 410(6824): 50-56.
6. -/- mice reveals a role for chemokines in the initiation of atherosclerosis. Nature 1998; 394(6696): 894-897.
7. Vogels MT, van der Meer JW. Interleukin-8 and adult respiratory distress syndrome. Lancet 1993; 341(8856): 1356,1357.
8. Hall IP, Wheatley A, Christie G, McDougall C, Hubbard R, Helms PJ. Association of CCR5 delta32 with reduced risk of asthma. Lancet 1999; 354(9186): 1264,1265.
9. Whyte A, Binns RM. RANTES and chemokines in rheumatoid arthritis. Lancet 1994; 343(8908): 1291,1292.
10. Christopherson 2nd KW, Campbell JJ, Travers JB, Hromas RA. Low-molecular-weight heparins inhibit CCL21-induced T cell adhesion and migration. J Pharmacol Exp Ther 2002; 302(1): 290-295.
11. Grone HJ, Weber C, Weber KS, et al. Met-RANTES reduces vascular and tubular damage during acute renal transplant rejection: blocking monocyte arrest and recruitment. FASEB J 1999; 13(11): 1371-1383.
12. Li XC, Zand MS, Li Y, Zheng XX, Strom TB. On histocompatibility barriers, Th1 to Th2 immune deviation, and the nature of the allograft responses. J Immunol 1998; 161(5): 2241-2247.
13. Sayegh MH, Akalin E, Hancock WW, et al. CD28-B7 blockade after alloantigenic challenge in vivo inhibits Th1 cytokines but spares Th2. J Exp Med 1995; 181(5): 1869-1874.
14. Gerber BO, Zanni MP, Uguccioni M, et al. Functional expression of the eotaxin receptor CCR3 in T lymphocytes co-localizing with eosinophils. Curr Biol 1997; 7(11): 836-843.
15. Loetscher P, Uguccioni M, Bordoli L, et al. CCR5 is characteristic of Th1 lymphocytes. Nature 1998; 391(6665): 344,345.
16. Bromley SK, Peterson DA, Gunn MD, Dustin ML. Cutting edge: hierarchy of chemokine receptor and TCR signals regulating T cell migration and proliferation. J Immunol 2000; 165(1): 15-19.
17. Sallusto F, Lanzavecchia A. Understanding dendritic cell and T-lymphocyte traffic through the analysis of chemokine receptor expression. Immunol Rev 2000; 177: 134-140.
18. Paule MF, McColl SR, Simeonovic CJ. Murine chemokine gene expression in rejecting pig proislet xenografts. Transplant Proc 2000; 32(5): 1062.
19. Gao W, Faia KL, Csizmadia V, et al. Beneficial effects of targeting CCR5 in allograft recipients. Transplantation 2001; 72(7): 1199-1205.
20. Melter M, Exeni A, Reinders ME, et al. Expression of the chemokine receptor CXCR3 and its ligand IP-10 during human cardiac allograft rejection. Circulation 2001; 104(21): 2558-2564.
21. Segerer S, Cui Y, Eitner F. Expression of chemokines and chemokine receptors during human renal transplant rejection. Am J Kidney Dis 2001; 37(3): 518-531.
22. Abdi R, Tran TB, Sahagun-Ruiz A, et al. Chemokine receptor polymorphism and risk of acute rejection in human renal transplantation. J Am Soc Nephrol 2002; 13(3): 754-758.
23. Abdi R, Smith RN, Makhlouf L. The role of CC chemokine receptor 5 (CCR5) in islet allograft rejection. Diabetes 2002; 51(8): 2489-2495.
24. Hancock WW, Lu B, Gao W, et al. Requirement of the chemokine receptor CXCR3 for acute allograft rejection. J Exp Med 2000; 192(10): 1515-1520.